Loading...
•
Oct 30, 2020
Medtronic Q2 2021 Earnings Report
Medtronic's Q2 2021 financial results were reported.
Key Takeaways
Medtronic reported a decrease in revenue by 0.8% to $7.6 billion. The GAAP diluted EPS was $0.36, and the non-GAAP diluted EPS was $1.02.
Q2 Revenue of $7.6 Billion decreased 0.8% as reported and 1.5% organic.
Q2 GAAP Diluted EPS of $0.36
Q2 Non-GAAP Diluted EPS of $1.02
Second quarter U.S. revenue of $4.054 billion represented 53 percent of company revenue and decreased 2 percent as reported and organic.
Medtronic
Medtronic
Medtronic Revenue by Segment
Medtronic Revenue by Geographic Location
Revenue by Segment
Cardiac Rhythm & HF Revenue
CapyFin.comCoronary & Peripheral Vascular Revenue
CapyFin.comCranial & Spinal Technologies Revenue
CapyFin.comSpecialty Therapies Revenue
CapyFin.comNeuromodulation Revenue
CapyFin.comSurgical & Endoscopy Revenue
CapyFin.comAcute Care & Monitoring Revenue
CapyFin.comDiabetes Revenue
CapyFin.comOther Segment Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income